Results
|
|
2001.
|
|
|
|
2002.
|
|
|
|
2003.
|
|
|
|
2004.
|
Corrigendum to "Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's antiseizure efficacy" [Neuropharmacology 143 (2018) 186-204]. [electronic resource] by
- Brandt, Claudia
- Seja, Patricia
- Töllner, Kathrin
- Römermann, Kerstin
- Hampel, Philip
- Kalesse, Markus
- Kipper, Andi
- Feit, Peter W
- Lykke, Kasper
- Toft-Bertelsen, Trine Lisberg
- Paavilainen, Pauliina
- Spoljaric, Inkeri
- Puskarjov, Martin
- MacAulay, Nanna
- Kaila, Kai
- Löscher, Wolfgang
Publication details: Neuropharmacology 12 2018
In:
Neuropharmacology vol. 143
Availability: No items available.
|
|
|
2005.
|
|
|
|
2006.
|
|
|
|
2007.
|
Discovery of a non-toxic [1,2,4]triazolo[1,5-a]pyrimidin-7-one (WS-10) that modulates ABCB1-mediated multidrug resistance (MDR). [electronic resource] by
- Chang, Liming
- Xiao, Mengwu
- Yang, Linlin
- Wang, Shuai
- Wang, Sai-Qi
- Bender, Andreas
- Hu, Aixi
- Chen, Zhe-Sheng
- Yu, Bin
- Liu, Hong-Min
Publication details: Bioorganic & medicinal chemistry 12 2018
In:
Bioorganic & medicinal chemistry vol. 26
Availability: No items available.
|
|
|
2008.
|
|
|
|
2009.
|
|
|
|
2010.
|
Publisher Correction: Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys. [electronic resource] by
- Borducchi, Erica N
- Liu, Jinyan
- Nkolola, Joseph P
- Cadena, Anthony M
- Yu, Wen-Han
- Fischinger, Stephanie
- Broge, Thomas
- Abbink, Peter
- Mercado, Noe B
- Chandrashekar, Abishek
- Jetton, David
- Peter, Lauren
- McMahan, Katherine
- Moseley, Edward T
- Bekerman, Elena
- Hesselgesser, Joseph
- Li, Wenjun
- Lewis, Mark G
- Alter, Galit
- Geleziunas, Romas
- Barouch, Dan H
Publication details: Nature 12 2018
In:
Nature vol. 564
Availability: No items available.
|
|
|
2011.
|
|
|
|
2012.
|
|
|
|
2013.
|
|
|
|
2014.
|
|
|
|
2015.
|
|
|
|
2016.
|
|
|
|
2017.
|
|
|
|
2018.
|
|
|
|
2019.
|
|
|
|
2020.
|
|